These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28150923)

  • 21. The UK National Screening Committee's position on child-parent screening for familial hypercholesterolaemia.
    Wald DS; Neely D
    J Med Screen; 2021 Sep; 28(3):217-220. PubMed ID: 34292841
    [No Abstract]   [Full Text] [Related]  

  • 22. Lipid Screening in Children.
    Daniels SR
    J Am Coll Cardiol; 2015 Sep; 66(11):1258-1260. PubMed ID: 26361157
    [No Abstract]   [Full Text] [Related]  

  • 23. What Is the Optimum Approach to Screening for Familial Hypercholesterolemia in Children?
    Daniels SR
    JAMA Pediatr; 2023 Jun; 177(6):565-566. PubMed ID: 37126321
    [No Abstract]   [Full Text] [Related]  

  • 24. Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.
    O'Brien EC; Roe MT; Fraulo ES; Peterson ED; Ballantyne CM; Genest J; Gidding SS; Hammond E; Hemphill LC; Hudgins LC; Kindt I; Moriarty PM; Ross J; Underberg JA; Watson K; Pickhardt D; Rader DJ; Wilemon K; Knowles JW
    Am Heart J; 2014 Mar; 167(3):342-349.e17. PubMed ID: 24576518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hypercholesterolemia in children and young adults: should screening be done?].
    Keller U
    Schweiz Med Wochenschr; 1995 Feb; 125(7):255-63. PubMed ID: 7878403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Universal Screening for Familial Hypercholesterolemia in Children.
    Klančar G; Grošelj U; Kovač J; Bratanič N; Bratina N; Trebušak Podkrajšek K; Battelino T
    J Am Coll Cardiol; 2015 Sep; 66(11):1250-1257. PubMed ID: 26361156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of Familial Hypercholesterolemia in Adolescents: Potential Value of Universal Screening?
    Pang J; Martin AC; Mori TA; Beilin LJ; Watts GF
    J Pediatr; 2016 Mar; 170():315-6. PubMed ID: 26690851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening methods in the diagnosis and assessment of children and adolescents with familial hypercholesterolemia.
    Langslet G; Ose L
    Expert Rev Cardiovasc Ther; 2013 Aug; 11(8):1061-6. PubMed ID: 23984929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Familial hypercholesterolemia. Screening, prevention and therapeutic possibilities].
    Vierucci A; Biadaioli R; De Martino M; Pratesi F; Novembre E; Morotti P
    Minerva Pediatr; 1982 Apr; 34(8):325-36. PubMed ID: 7048049
    [No Abstract]   [Full Text] [Related]  

  • 30. Diagnosis and case finding in familial hypercholesterolemia.
    Pearson TA
    Am J Cardiol; 1993 Sep; 72(10):15D-17D. PubMed ID: 8213491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Familial hypercholesterolaemia: Child-parent screening may have adverse psychological effects.
    Hopcroft KA
    BMJ; 2007 Oct; 335(7622):683. PubMed ID: 17916819
    [No Abstract]   [Full Text] [Related]  

  • 32. Future issues, public policy, and public awareness of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
    Goldberg AC; Robinson JG; Cromwell WC; Ross JL; Ziajka PE
    J Clin Lipidol; 2011 Jun; 5(3 Suppl):S46-51. PubMed ID: 21600529
    [No Abstract]   [Full Text] [Related]  

  • 33. ScreenPro FH - Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Rationale and Design.
    Češka R; Paragh G; Reiner Ž; Banach M; Tokgözoğlu L; Susekov AV; Rašlová K; Freiberger T; Vohnout B; Rynkiewicz A; Goudev A; Dan GA; Gaiţă D; Pojskić B; Pećin I; Kayıkçıoğlu M; Mitchenko O; Ezhov MV; Latkovskis G; Petrulionienė Ž; Fras Z; Tasić N; Mirrakhimov EM; Murataliev T; Shek AB; Tuka V; Tselepis AD; Moubarak EM; Rasadi KA
    Vnitr Lek; 2017; 63(1):43-48. PubMed ID: 28225290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The characteristics of patients with possible familial hypercholesterolemia: screening a large payer/provider healthcare delivery system.
    Elis A
    QJM; 2021 Feb; 114(1):67. PubMed ID: 32810264
    [No Abstract]   [Full Text] [Related]  

  • 35. The characteristics of patients with possible familial hypercholesterolemia: screening a large payer/provider healthcare delivery system.
    Watanabe A; Ito H
    QJM; 2021 Feb; 114(1):66. PubMed ID: 32810258
    [No Abstract]   [Full Text] [Related]  

  • 36. Identification of people with heterozygous familial hypercholesterolemia.
    Haase A; Goldberg AC
    Curr Opin Lipidol; 2012 Aug; 23(4):282-9. PubMed ID: 22801386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Historical xanthomata revealing a familial hypercholesterolemia type IIa].
    El Guendouz F; Baïzri H
    Pan Afr Med J; 2015; 21():252. PubMed ID: 26523189
    [No Abstract]   [Full Text] [Related]  

  • 38. Detecting familial hypercholesterolemia: The Jack and the Beanstalk principle.
    Martin AC; Allen C; Pang J; Watts GF
    J Clin Lipidol; 2017; 11(2):575-578. PubMed ID: 28502516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Finding Importance for Universal Screening of Familial Hypercholesterolemia.
    Yokoyama S
    J Atheroscler Thromb; 2022 Jun; 29(6):814-815. PubMed ID: 34248088
    [No Abstract]   [Full Text] [Related]  

  • 40. [Screening for familial hypercholesterolemia].
    Cariou B; Krempf M
    Rev Prat; 2011 Oct; 61(8):1106-7. PubMed ID: 22135978
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.